You just read:

Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder

News provided by

Avanir Pharmaceuticals, Inc.

Aug 26, 2014, 09:00 ET